Adam Tomasi
President bei ALLAKOS INC.
Vermögen: 779 011 $ am 31.03.2024
Profil
Dr. Adam L. Tomasi ist President & Chief Operating Officer bei Allakos, Inc. Er ist Mitglied des Board of Directors bei Attune Pharmaceuticals, Inc. Dr. Tomasi war zuvor als Chief Scientific Officer bei ZS Pharma, Inc. beschäftigt, als Principal bei Alta Partners Management Corp. und als medizinischer Chemiker bei Cytokinetics, Inc. sowie bei Gilead Sciences, Inc. Er erhielt seinen Bachelor-Abschluss von der University of California, Berkeley, einen MBA von der MIT Sloan School of Management und einen Doktortitel von der University of California, Irvine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALLAKOS, INC.
0,70% | 05.03.2024 | 618 263 ( 0,70% ) | 779 011 $ | 31.03.2024 |
Aktive Positionen von Adam Tomasi
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLAKOS INC. | President | 01.08.2019 |
Attune Pharmaceuticals, Inc.
 Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Director/Board Member | - |
LifeSci Acquisition III Corp.
 LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Director/Board Member | - |
Ehemalige bekannte Positionen von Adam Tomasi
| Unternehmen | Position | Ende |
|---|---|---|
| ZS PHARMA INC | Chief Tech/Sci/R&D Officer | 01.03.2017 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Private Equity Investor | - |
Ausbildung von Adam Tomasi
| University of California, Berkeley | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| ALLAKOS INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Finance |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
Attune Pharmaceuticals, Inc.
Attune Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Attune Pharmaceuticals, Inc. engages in the provision of biotechnology services. It discovers and develops orally-administered small-molecule therapeutics for the treatment of rare diseases. The company was founded by Andrew Ian McDonald and is headquartered in New York, NY. | Commercial Services |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Finance |
